{
    "clinical_study": {
        "@rank": "60461", 
        "arm_group": {
            "arm_group_label": "theophylline", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "The aim of this study is to determine whether common CYP1A2 and CYP2E1 gene polymorphisms\n      effect metabolism of theophylline in chronic obstructive pulmonary disease patients."
        }, 
        "brief_title": "Association Between CytochromeP4501A2 and CytochromeP4502E1 Gene Polymorphisms and Metabolism of Theophylline", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Obstructive Pulmonary Disease", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged 18-75 years,COPD patients, male or female;\n\n          -  regularly visiting our hospital;\n\n          -  taking a sustained-release preparation of theophylline continuously for at least 2\n             weeks\n\n        Exclusion Criteria:\n\n          -  patients with renal or hepatic dysfunction;\n\n          -  patients with congestive heart failure;\n\n          -  patients with hypothyroidism or hyperthyroidism;\n\n          -  patients currently taking drugs likely to affect theophylline metabolism or who had\n             taken such drugs in the preceding week;\n\n          -  patients with extreme obesity\n\n          -  patients with very severe Chronic Obstructive Pulmonary Disease(COPD)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02001935", 
            "org_study_id": "81302846"
        }, 
        "intervention": {
            "arm_group_label": "theophylline", 
            "description": "After oral theophylline 200mg per day for two weeks,bood sample  will be collected for determining plasma concentrations of theophylline and it's metabolites and the genotypes of CYP1A2 and CYP2E1", 
            "intervention_name": "theophylline", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Theophylline"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "COPD", 
            "theophylline", 
            "CYP1A2", 
            "CYP2E1"
        ], 
        "lastchanged_date": "November 28, 2013", 
        "location": {
            "contact": {
                "email": "wliqing07@gmail.com", 
                "last_name": "Wang Liqing, doctor", 
                "phone": "+86-02062783391"
            }, 
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510282"
                }, 
                "name": "Zhujiang Hospital,Southern Medical Universtiy"
            }, 
            "investigator": {
                "last_name": "Wang Liqing, doctor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "Association Between CytochromeP4501A2(CYP1A2) and CytochromeP4502E1(CYP2E1) Gene Polymorphisms and Metabolism of Theophylline in a Chinese Population", 
        "overall_contact": {
            "email": "wliqing07@gmail.com", 
            "last_name": "Wang Liqing, Doctor", 
            "phone": "+86-02062783391"
        }, 
        "overall_official": {
            "affiliation": "Zhujiang Hospital,Southern Medical Unversity", 
            "last_name": "Wang Liqing, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Theophylline and it's metabolite(1,3-dimethyluric) blood concentration", 
            "measure": "Theophylline clearance", 
            "safety_issue": "No", 
            "time_frame": "Blood samples will be taken after receiving oral  thoephylline for 14 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02001935"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Zhujiang Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Zhujiang Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}